← Back to Search

Catheter

Mechanical Thrombectomy for Stroke (EXCELLENT Trial)

N/A
Recruiting
Led By Raul Nogueira, MD
Research Sponsored by Cerenovus, Part of DePuy Synthes Products, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Summary

A post-market registry evaluating the EmboTrap® Revascularization Device, CERENOVUS Large Bore Catheter/ EMBOVAC™ Aspiration Catheter, and CEREGLIDE 71 Intermediate Catheter in acute ischemic stroke patients with confirmed intracranial vessel occlusion.

Eligible Conditions
  • Stroke

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Successful Revascularization
Secondary outcome measures
All-Cause Mortality
Functional Independence
Symptomatic Intracerebral Hemorrhage

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mechanical ThrombectomyExperimental Treatment3 Interventions
EmboTrap® Revascularization Device, CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter, CEREGLIDE 71 Intermediate Catheter
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EmboTrap® Revascularization Device
2015
N/A
~230

Find a Location

Who is running the clinical trial?

Cerenovus, Part of DePuy Synthes Products, Inc.Lead Sponsor
8 Previous Clinical Trials
3,571 Total Patients Enrolled
1 Trials studying Stroke
2,000 Patients Enrolled for Stroke
Neuravi LimitedLead Sponsor
3 Previous Clinical Trials
194 Total Patients Enrolled
3 Trials studying Stroke
194 Patients Enrolled for Stroke
Raul Nogueira, MDPrincipal InvestigatorUPMC Stroke Institute
3 Previous Clinical Trials
652 Total Patients Enrolled
3 Trials studying Stroke
652 Patients Enrolled for Stroke
~154 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top